Clinical Research Directory
Browse clinical research sites, groups, and studies.
CYPRESS Efficacy and Safety Study Extension
Sponsor: SightGlass Vision, Inc.
Summary
This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Official title: Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study Extension
Key Details
Gender
All
Age Range
6 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-07-19
Completion Date
2026-03-31
Last Updated
2024-12-20
Healthy Volunteers
Yes
Conditions
Interventions
Novel spectacle lens design
Use of single vision, impact resistant spectacle lenses may reduce the rate of progression of juvenile myopia
Spectacle lenses
Single vision, impact resistant spectacle lenses
Locations (12)
Golden Optometric Group
Whittier, California, United States
Omega Vision Center, PA
Longwood, Florida, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Haik Humble
West Monroe, Louisiana, United States
Advanced Eyecare PC
Raytown, Missouri, United States
SUNY School of Optometry
New York, New York, United States
Sacco Eye Group
Vestal, New York, United States
Dunes Eye Consultants
Dakota Dunes, South Dakota, United States
Total Eye Care
Memphis, Tennessee, United States
Dr. Bridgitte Shen Lee (PI)
Houston, Texas, United States
William J Bogus, OD, FAAO
Salt Lake City, Utah, United States
Centre for Ocular Research and Education
Waterloo, Ontario, Canada